Table 1.
Clinical and biochemical data from PCOS and control patients.
| Variables | PCOS (n = 792) | non-PCOS (n = 700) |
|---|---|---|
| Age | 29(27–32.5) | 31(28–35)** |
| Systolic pressur (mmHg) | 116(106–126.5) | 109(103–117)** a |
| Diastolic pressure (mmHg) | 77(68–83) | 72(67–77)** a |
| BMI (kg/m2) | 23.73(21.48–26.85) | 21.64(19.53–23.88)** |
| WC (cm) | 84(77–90.5) | 75(70–81)** |
| HC (cm) | 94(90–101) | 90(86–96)* |
| Waist–hip ratio | 0.88(0.85–0.91) | 0.83(0.79–0.87)** |
| Basal serum PRL (mIU/L) | 235.74(186.85–318.03) | 275.13(213.60–355.84)* b |
| Basal serum LH (IU/L) | 9.09(6.26–13.44) | 4.65(3.48–5.98)** b |
| Basal serum FSH (IU/L) | 6.62(5.86–7.81) | 7.82(6.67–9.02)** b |
| LH/FSH | 1.37(0.89–1.96) | 0.59(0.42–0.77)** b |
| Basal serum E2 (pmol/L) | 180(113.5–238.5) | 182.5(134.5–238) |
| Basal serum T (nmol/L) | 2.15(1.59–2.75) | 1.56(1.25–1.96)** b |
| FINS (pmol/L) | 82.9(50.35–112.30) | 52.75(37.6–75.6)** a |
| FPG (mmol/L) | 5.2(4.9–5.5) | 5.1(4.9–5.4) |
| HOMA-IR | 2.74(1.75–3.76) | 1.74(1.22–2.55)** a |
| HOMA- β | 137.49(88.35–216.24) | 93.45(67.08–128.42)** a |
| TG (mmol/L) | 1.37(0.94–1.98) | 0.93(0.69–1.24)** b |
| TC (mmol/L) | 4.79(4.20–5.30) | 4.48(3.99–4.98)** a |
| LDL-C (mmol/L) | 2.74(2.31–3.28) | 2.49(2.10–2.92)** a |
| HDL-C (mmol/L) | 1.29(1.12–1.46) | 1.40(1.23–1.61)** a |
| AST (U/L) | 18(16–22.5) | 16(14–19)** b |
| ALT (U/L) | 21(15–28) | 14(11–20.5)** b |
Parameters were not normally distributed and data are presented as quartiles. The rank sum test was used to compare differences between patients and controls.
*P < 0.05 versus controls, **P < 0.001 versus controls.
a
P < 0.05 versus controls after correcting for age and BMI.
b
P < 0.001 versus controls after correcting for age and BMI.